AU553507B2 - Fatty emulsion for parenteral administration of food - Google Patents

Fatty emulsion for parenteral administration of food

Info

Publication number
AU553507B2
AU553507B2 AU86965/82A AU8696582A AU553507B2 AU 553507 B2 AU553507 B2 AU 553507B2 AU 86965/82 A AU86965/82 A AU 86965/82A AU 8696582 A AU8696582 A AU 8696582A AU 553507 B2 AU553507 B2 AU 553507B2
Authority
AU
Australia
Prior art keywords
triglycerides
carbon atoms
fatty acids
chain fatty
food
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU86965/82A
Other versions
AU8696582A (en
Inventor
Jorg Nehne
Wilhelm Niemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
B Braun Holding AG
Original Assignee
Intermedicat GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6138910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU553507(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intermedicat GmbH filed Critical Intermedicat GmbH
Publication of AU8696582A publication Critical patent/AU8696582A/en
Application granted granted Critical
Publication of AU553507B2 publication Critical patent/AU553507B2/en
Assigned to B.Braun Holding AG reassignment B.Braun Holding AG Request to Amend Deed and Register Assignors: B. Braun-Ssc A.G.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Abstract

1. An isotonic emulsion composition adapted for parenteral use comprising triglycerides of long-chain fatty acids having from 16 to 18 carbon atoms (LCT) and triglycerides of medium-chain fatty acids having from 8 to 12 carbon atoms (MCT), wherein the total fat content is from 3 to 30% and the ratio LCT/MCT (triglycerides of long-chain fatty acids having from 16 to 18 carbon atoms/triglycerides of medium-chain fatty acids having from 8 to 12 carbon atoms) is from 4:1 to 1:4, and a content of physiologically acceptable polyvalent alcohols, characterized in that the emulsion contains an egg phosphatide as the emulsifier.
AU86965/82A 1981-08-08 1982-08-06 Fatty emulsion for parenteral administration of food Ceased AU553507B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE31314600 1981-08-08
DE19813131460 DE3131460A1 (en) 1981-08-08 1981-08-08 FAT EMULSION FOR PARENTERAL NUTRITION

Publications (2)

Publication Number Publication Date
AU8696582A AU8696582A (en) 1983-02-17
AU553507B2 true AU553507B2 (en) 1986-07-17

Family

ID=6138910

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86965/82A Ceased AU553507B2 (en) 1981-08-08 1982-08-06 Fatty emulsion for parenteral administration of food

Country Status (6)

Country Link
EP (1) EP0071995B1 (en)
JP (1) JPS5841825A (en)
AT (1) ATE17316T1 (en)
AU (1) AU553507B2 (en)
DE (2) DE3131460A1 (en)
FI (1) FI822733L (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59172416A (en) * 1983-03-18 1984-09-29 Terumo Corp Fat transfusion solution
JPS61501558A (en) * 1984-01-16 1986-07-31 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテッド Parenteral nutritional supplementation of medium and long chain triglycerides
US4703062A (en) * 1984-01-16 1987-10-27 Baxter Travenol Laboratories, Inc. Parenteral nutrition with medium and long chain triglycerides
US4678807A (en) * 1984-03-01 1987-07-07 Baxter Travenol Laboratories, Inc. Method for directed visceral metabolism of medium chain triglycerides
DE3524788A1 (en) * 1985-07-11 1987-01-22 Lentia Gmbh STABLE, INTRAVENOES APPLICABLE, AQUEOUS FAT EMULSION AND A METHOD FOR THE PRODUCTION THEREOF
US4678808A (en) * 1985-10-15 1987-07-07 Baxter Travenol Laboratories, Inc. Rapid acting intravenous emulsions of omega-3 fatty acid esters
SE8505047L (en) * 1985-10-25 1987-04-26 Nutritional Int Res Inst fat emulsion
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
JP2518636B2 (en) * 1987-02-13 1996-07-24 雪印乳業株式会社 Enteral nutrition for the treatment of severe infections and widespread fever
US4810726A (en) * 1987-04-01 1989-03-07 New England Deaconess Hospital Corporation Kernel oils and disease treatment
DE3721137A1 (en) * 1987-06-26 1989-01-05 Dietl Hans Fat emulsion for intravenous use
EP0537113A1 (en) * 1991-10-10 1993-04-14 SANDOZ NUTRITION Ltd. Energy supplementary food
US5344822A (en) * 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
JPS6030652B2 (en) * 1979-05-07 1985-07-17 株式会社ミドリ十字 Fat emulsion for intravenous injection
DE3032300A1 (en) * 1980-08-27 1982-04-01 Alfred Ing. Wien Lohninger Parenteral nutrition fatty emulsion - contg. fatty acid tri:glyceride(s), glycerol, carnitine or acyl-carnitine, phospholipid, and carrier or diluent

Also Published As

Publication number Publication date
JPS5841825A (en) 1983-03-11
FI822733L (en) 1983-02-09
DE3268400D1 (en) 1986-02-20
EP0071995B1 (en) 1986-01-08
EP0071995A2 (en) 1983-02-16
EP0071995A3 (en) 1983-10-05
ATE17316T1 (en) 1986-01-15
AU8696582A (en) 1983-02-17
JPH0465048B2 (en) 1992-10-16
DE3131460A1 (en) 1983-02-24
FI822733A0 (en) 1982-08-05

Similar Documents

Publication Publication Date Title
DE3881815D1 (en) ISOTONE OMEGA-3 FATTY ACID FAT EMULSION AND THEIR USE.
AU553507B2 (en) Fatty emulsion for parenteral administration of food
MXPA98002779A (en) Therapeutic diet for metabolic abnormalities found in animals with lymphoma.
CA2418350A1 (en) Oil/fat composition
NL990032I2 (en) Fat emulsion, process for its preparation and use.
AU643763B2 (en) Fats rich in behenic and stearic and/or palmitic acids
AU8146091A (en) Spread with low saturated fat content
AU573460B2 (en) Improvements in and relating to margarine and like fat compositions
DK0456764T3 (en) Omega-3 fatty acid-containing fat emulsion for endotracheal administration, preparation and use thereof
JPS5747446A (en) Nutrious food composition
AU604492B2 (en) Multifunctional, fat-continuous emulsions with a reduced fat content
DK0724389T3 (en) Low palmitic acid and reduced trans acid content margarines and shortening products
AU2967889A (en) Fat-containing compositions having a low phosphatide content

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired